Genmab (GMAB)
(Delayed Data from NSDQ)
$28.15 USD
+0.69 (2.51%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $28.14 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/2/24 |
---|---|
Current Quarter | 0.16 |
EPS Last Quarter | 0.36 |
Last EPS Surprise | 5.88% |
ABR | 2.18 |
Earnings ESP
|
-10.97% |
---|---|
Current Year | 1.06 |
Next Year | 1.44 |
EPS (TTM) | 1.18 |
P/E (F1) | 26.53 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 594.23M | 715.20M | 2.81B | 3.43B |
# of Estimates | 4 | 3 | 6 | 5 |
High Estimate | 679.07M | 738.92M | 2.84B | 3.63B |
Low Estimate | 559.02M | 693.22M | 2.73B | 3.31B |
Year ago Sales | 411.37M | 613.43M | 2.39B | 2.81B |
Year over Year Growth Est. | 44.45% | 16.59% | 17.33% | 22.20% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.16 | 0.31 | 1.06 | 1.44 |
# of Estimates | 7 | 5 | 9 | 8 |
Most Recent Consensus | 0.14 | 0.28 | 0.88 | 1.05 |
High Estimate | 0.26 | 0.37 | 1.23 | 1.78 |
Low Estimate | 0.14 | 0.26 | 0.88 | 1.05 |
Year ago EPS | 0.05 | 0.30 | 1.18 | 1.06 |
Year over Year Growth Est. | 220.00% | 3.33% | -10.17% | 35.98% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 2 | 3 |
Up Last 60 Days | 0 | 0 | 2 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 2 | 2 |
Down Last 60 Days | 0 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.16 | 0.31 | 1.06 | 1.44 |
7 Days Ago | 0.16 | 0.31 | 1.06 | 1.44 |
30 Days Ago | 0.17 | 0.31 | 1.09 | 1.49 |
60 Days Ago | 0.17 | 0.31 | 1.09 | 1.49 |
90 Days Ago | 0.15 | 0.29 | 1.16 | 1.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.15 | 0.33 | 1.10 | 1.49 |
Zacks Consensus Estimate | 0.16 | 0.31 | 1.06 | 1.44 |
Earnings ESP | -10.97% | 5.52% | 3.43% | 3.02% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.36 | 0.47 | 0.30 | 0.05 | NA |
Estimate | 0.34 | 0.34 | 0.31 | 0.09 | NA |
Difference | 0.02 | 0.13 | -0.01 | -0.04 | 0.03 |
Surprise | 5.88% | 38.24% | -3.23% | -44.44% | -0.89% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more